Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alcon Inc. Ordinary Shares (NY: ALC )

93.31 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Feb 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alcon Inc. Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >
10 Biggest Price Target Changes For Thursday
Needham boosted the price target on NVIDIA Corporation (NASDAQ: 
Via Benzinga
46 Biggest Movers From Yesterday
Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares climbed 189.5% to close at $9.90 on Wednesday after surging over 15% on Tuesday. SGOCO Group, Ltd. (NASDAQ: SGOC) surged 67... 
Via Benzinga
Alcon inc (ALC) Q2 2021 Earnings Call Transcript
ALC earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Mid-Afternoon Market Update: Crude Oil Down 1.5%; Tuya Shares Plummet
Toward the end of trading Wednesday, the Dow traded down 0.27% to 35,249.25 while the NASDAQ rose 0.06% to 14,664.67. The S&P also fell, dropping 0.21% to 4,438.73. The U.S.... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Mid-Day Market Update: Alcon Rises Following Q2 Results; NexPoint Real Estate Finance Shares Slide
Midway through trading Wednesday, the Dow traded down 0.12% to 35,299.82 while the NASDAQ fell 0.01% to 14,654.93. The S&P also fell, dropping 0.10% to 4,443.63. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
34 Stocks Moving In Wednesday's Mid-Day Session
Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 139% to $8.18 after surging over 15% on Tuesday. Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 58% to $... 
Via Benzinga
22 Stocks Moving in Wednesday's Pre-Market Session
Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares rose 50.6% to $23.12 in pre-market trading. Virpax Pharmaceuticals shares jumped 265% on Tuesday after the company... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Mostly Lower Ahead Of Fed Minutes
Pre-open movers U.S. stock futures traded mostly lower in early pre-market trade ahead of the release of minutes from the Fed meeting. Investors are awaiting earnings results from... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Investors Cheer Alcon's Updated Annual Guidance
Alcon AG (NYSE: ALC) reported second-quarter FY21 sales of $2.1 billion, +75% Y/Y on a reported basis and +69% on a constant currency basis, beating the consensus of $1... 
Via Benzinga
Alcon Reports Second Quarter 2021 Results
From Alcon Inc. Investors
Via Business Wire
Earnings Scheduled For August 17, 2021
Companies Reporting Before The Bell • AiHuiShou Intl (NYSE:RERE) is expected to report earnings for its second quarter. • Ozon Holdings (NASDAQ:OZON) is expected... 
Via Benzinga
Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens
From Alcon Inc. Investors
Via Business Wire
Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021
From Alcon Inc. Investors
Via Business Wire
Alcon Announces Executive Committee Changes
From Alcon Inc. Investors
Via Business Wire
Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021
From Alcon Inc. Investors
Via Business Wire
Alcon Inc (ALC) Q1 2021 Earnings Call Transcript
ALC earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Alcon's Q1 Sales Boosted By Equipment, Implantables In Surgical Segment, FY21 Outlook In-Line With Expectations
Alcon AG (NYSE: ALC) reported first-quarter FY21 sales of $1.9 billion, an increase of 5% Y/Y on a reported basis and 2% on a constant currency basis,... 
Via Benzinga
Alcon Reports First Quarter 2021 Results
From Alcon Inc. Investors
Via Business Wire
Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza
From Alcon Inc. Investors
Via Business Wire
Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S.
From Alcon Inc. Investors
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.